| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |